샘플 요청 목록

 카트 문의
시장보고서
상품코드
1779737

세계의 셀 뱅킹 아웃소싱 시장

Cell Banking Outsourcing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 366 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 셀 뱅킹 아웃소싱 시장은 2030년까지 340억 달러에 달할 전망

2024년에 139억 달러로 추정되는 세계의 셀 뱅킹 아웃소싱 시장은 2024-2030년에 CAGR 16.1%로 성장하며, 2030년에는 340억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 마스터 셀 뱅킹은 CAGR 18.5%를 기록하며, 분석 기간 종료시에는 197억 달러에 달할 것으로 예상됩니다. 워킹 셀 뱅킹 부문의 성장률은 분석 기간 중 CAGR 14.8%로 추정됩니다.

미국 시장은 38억 달러로 추정, 중국은 CAGR 21.7%로 성장할 것으로 예측

미국의 셀 뱅킹 아웃소싱 시장은 2024년에 38억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 76억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 21.7%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 11.6%와 14.6%로 예측됩니다. 유럽에서는 독일이 CAGR 약 12.9%로 성장할 것으로 예측됩니다.

세계의 셀 뱅킹 아웃소싱 시장 - 주요 동향과 촉진요인 정리

셀뱅킹 아웃소싱에 대한 수요가 증가하는 이유는 무엇인가?

셀뱅킹 아웃소싱에 대한 수요가 증가하고 있는 이유는 세포 기반 치료, 재생의료, 바이오의약품 연구의 채택이 증가하고 있기 때문입니다. 제약사 및 생명공학 기업이 세포치료, 유전자치료, 맞춤의료, 백신 제조 개발에 집중하는 가운데, 고품질의 잘 보존된 세포주에 대한 수요가 크게 증가하고 있습니다. 세포은행 서비스 아웃소싱을 통해 연구기관이나 의약품 개발 기업은 비용이 많이 드는 내부 인프라를 유지해야 하는 부담 없이 세포주를 보존, 증식, 관리할 수 있습니다.

줄기세포치료, 모노클로널 항체, 바이오의약품 임상시험 증가는 셀뱅킹 아웃소싱에 대한 수요를 더욱 촉진하고 있습니다. 세포 기반 제품 개발은 복잡하므로 엄격한 품질관리, 적정 제조 기준(GMP) 준수, 안전한 장기 보관이 요구되며, 아웃소싱은 비용 최적화와 규제 준수를 원하는 기업에게 매력적인 선택이 되고 있습니다. 또한 맞춤형 의료가 진화하면서 세포주의 안전성, 추적성, 생존성 확보가 중요해짐에 따라 신뢰할 수 있는 전문적인 세포은행 서비스에 대한 요구가 더욱 높아지고 있습니다.

기술의 발전은 셀뱅킹 아웃소싱을 어떻게 개선하고 있는가?

냉동 보존, 자동 바이오프로세스, 품질 보증 기술의 혁신은 셀뱅킹 아웃소싱에 혁명을 일으켜 세포 장기 보존의 효율성과 신뢰성을 향상시키고 있습니다. 가장 중요한 발전 중 하나는 고급 동결 보호제와 제어된 동결 속도 기술 개발로, 이를 통해 보존 세포의 생존율과 안정성이 향상되었습니다. 이러한 혁신은 유전자 드리프트와 세포 열화의 위험을 줄이고, 연구 및 치료 용도에서 생물학적 샘플의 장기적인 가용성을 보장합니다.

또 다른 큰 혁신은 세포은행 업무에 인공지능과 자동화를 통합한 것입니다. AI를 활용한 예측 분석과 로봇을 이용한 핸들링 시스템은 프로세스의 일관성을 향상시키고, 인적 오류를 줄이며, 보관 조건을 최적화하고 있습니다. 또한 안전한 데이터 관리와 추적성을 위해 블록체인 기술이 검토되고 있으며, 셀뱅킹 기록의 완전한 투명성과 컴플라이언스를 보장하기 위해 블록체인 기술이 검토되고 있습니다. 클라우드 기반 시료 추적 및 디지털 재고 관리 시스템을 채택하여 업무 효율성을 더욱 높이고, 고객이 보관하고 있는 세포주를 실시간으로 원격 모니터링 및 관리할 수 있도록 하고 있습니다.

셀뱅킹 아웃소싱 산업의 성장을 촉진하는 시장 동향은?

재생의료와 세포치료제 개발에 대한 관심 증가는 셀뱅킹 아웃소싱 시장을 형성하는 가장 영향력 있는 동향 중 하나입니다. 신경퇴행성 질환, 심혈관 질환, 희귀 유전성 질환 치료를 위한 줄기세포 연구가 활발해지면서 고품질 줄기세포 은행 서비스에 대한 수요가 증가하고 있습니다. 바이오제약 기업 역시 모노클로널 항체나 재조합 단백질을 포함한 생물제제의 대량 생산을 위해 세포은행 아웃소싱에 대한 의존도를 확대하고 있습니다.

시장 성장에 영향을 미치는 또 다른 주요 동향은 GMP(Good Manufacturing Practice)와 표준화된 세포 보존 프로토콜에 대한 규제 강화입니다. 전 세계 규제 당국이 세포치료제 제조 및 보관에 대한 가이드라인을 강화하는 가운데, 아웃소싱 업체들은 업계 표준을 충족하기 위해 더 높은 수준의 생물학적 안전성, GMP 준수 시설, 첨단 모니터링 시스템에 투자하고 있습니다. 또한 생명공학 연구 분야에서 국제적인 공동연구가 증가함에 따라 기업이 여러 지역에 걸쳐 고품질 세포주에 접근할 수 있는 중앙 집중식 세포은행 서비스에 대한 수요가 증가하고 있습니다. 세포 기반 연구와 치료법의 급속한 확대로 인해 세포은행 아웃소싱은 많은 생명과학 기업에게 전략적으로 필수적인 요소로 자리 잡고 있습니다.

셀뱅킹 아웃소싱 시장의 미래를 좌우할 주요 성장 동력은 무엇인가?

셀뱅킹 아웃소싱 시장의 성장은 세포 기반 치료에 대한 수요 증가, 바이오프리저베이션 기술의 발전, 바이오의약품 연구에 대한 투자 증가 등 여러 가지 요인에 의해 이루어지고 있습니다. 주요 성장 요인 중 하나는 세포치료제 및 유전자치료제 임상시험의 확대이며, 개발 및 규제 당국의 승인을 위해서는 안전하고 잘 관리된 세포주가 필요합니다. 제약회사와 연구기관이 재생의료에 대한 노력을 가속화하고 있는 가운데, 신뢰할 수 있는 세포은행 파트너의 필요성이 점점 더 커지고 있습니다.

시장을 형성하는 또 다른 중요한 촉진요인은 맞춤형 의료와 정밀 치료의 채택이 증가하고 있다는 점입니다. 세포 기반 치료가 환자 맞춤형으로 발전함에 따라 자가 및 동종 보존 서비스를 포함한 맞춤형 세포 은행 솔루션에 대한 수요가 증가하고 있습니다. 또한 바이오제약 기업과 위탁개발 및 제조수탁기관(CDMO)과의 제휴가 확대되면서 보다 확장 가능하고 비용 효율적인 아웃소싱 솔루션이 가능해졌습니다. 생명과학 산업이 혁신을 거듭하는 가운데, 셀뱅킹 아웃소싱은 치료법의 혁신을 촉진하고 시료의 장기적인 생존성을 보장하며 차세대 바이오의약품 개발을 지원하는 데 매우 중요한 역할을 할 것으로 기대됩니다.

부문

유형(마스터 셀 뱅킹, 워킹 셀 뱅킹, 바이러스 셀 뱅킹); 세포 유형(줄기세포, 비줄기세포); 단계(뱅크 보존 단계, 뱅크 특성 평가 및 시험 단계, 뱅크 준비 단계)

조사 대상 기업의 예

  • ATCC(American Type Culture Collection)
  • BioOutsource Ltd.
  • BioReliance Corporation
  • BSL Bioservice
  • CellBank Australia
  • Charles River Laboratories, Inc.
  • Clean Biologics
  • Cordlife Group Limited
  • Covance Inc.
  • Cryo-Cell International Inc.
  • Cryoviva India
  • Eurofins Scientific
  • GBI
  • LifeCell International Pvt. Ltd
  • Lonza Group Ltd.
  • Merck KGaA
  • Paragon Bioservices, Inc.
  • Reliance Life Sciences
  • Sartorius AG
  • SGS Life Sciences

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장과 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.06

Global Cell Banking Outsourcing Market to Reach US$34.0 Billion by 2030

The global market for Cell Banking Outsourcing estimated at US$13.9 Billion in the year 2024, is expected to reach US$34.0 Billion by 2030, growing at a CAGR of 16.1% over the analysis period 2024-2030. Master Cell Banking, one of the segments analyzed in the report, is expected to record a 18.5% CAGR and reach US$19.7 Billion by the end of the analysis period. Growth in the Working Cell Banking segment is estimated at 14.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.8 Billion While China is Forecast to Grow at 21.7% CAGR

The Cell Banking Outsourcing market in the U.S. is estimated at US$3.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.6 Billion by the year 2030 trailing a CAGR of 21.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.6% and 14.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.9% CAGR.

Global Cell Banking Outsourcing Market - Key Trends & Drivers Summarized

Why Is the Demand for Cell Banking Outsourcing Increasing?

The demand for cell banking outsourcing is increasing due to the rising adoption of cell-based therapies, regenerative medicine, and biopharmaceutical research. As pharmaceutical and biotechnology companies focus on the development of cell and gene therapies, personalized medicine, and vaccine production, the need for high-quality, well-preserved cell lines has grown significantly. Outsourcing cell banking services allows research institutions and drug developers to store, expand, and manage their cell lines without the burden of maintaining costly in-house infrastructure.

The increasing number of clinical trials for stem cell therapies, monoclonal antibodies, and biologics has further fueled the demand for cell banking outsourcing. The complexity of cell-based product development requires stringent quality control, compliance with Good Manufacturing Practices (GMP), and secure long-term storage, making outsourcing an attractive option for companies looking to optimize costs and ensure regulatory compliance. Additionally, as personalized medicine continues to evolve, there is a growing emphasis on ensuring the safety, traceability, and viability of cell lines, further driving the need for reliable and specialized cell banking services.

How Are Technological Advancements Improving Cell Banking Outsourcing?

Innovations in cryopreservation, automated bioprocessing, and quality assurance techniques are revolutionizing cell banking outsourcing, improving the efficiency and reliability of long-term cell storage. One of the most significant advancements is the development of advanced cryoprotectants and controlled-rate freezing technologies, which enhance the viability and stability of stored cells. These innovations reduce the risks of genetic drift and cell degradation, ensuring the long-term usability of biological samples for research and therapeutic applications.

Another major breakthrough is the integration of artificial intelligence and automation in cell banking operations. AI-driven predictive analytics and robotic handling systems are improving process consistency, reducing human error, and optimizing storage conditions. Additionally, blockchain technology is being explored for secure data management and traceability, ensuring full transparency and compliance in cell banking records. The adoption of cloud-based sample tracking and digital inventory management systems is further enhancing operational efficiency, allowing clients to remotely monitor and manage their stored cell lines in real time.

Which Market Trends Are Driving Growth in the Cell Banking Outsourcing Industry?

The increasing focus on regenerative medicine and cell therapy development is one of the most influential trends shaping the cell banking outsourcing market. With stem cell research gaining momentum for treating neurodegenerative disorders, cardiovascular diseases, and rare genetic conditions, demand for high-quality stem cell banking services is growing. Biopharmaceutical companies are also expanding their reliance on outsourced cell banking for large-scale production of biologics, including monoclonal antibodies and recombinant proteins.

Another key trend influencing market growth is the regulatory emphasis on Good Manufacturing Practices and standardized cell preservation protocols. As global regulatory agencies tighten guidelines on cell therapy manufacturing and storage, outsourcing providers are investing in higher biosafety levels, GMP-compliant facilities, and advanced monitoring systems to meet industry standards. Additionally, the rise of international collaborations in biotech research is driving demand for centralized cell banking services, allowing companies to access high-quality cell lines across multiple regions. With the rapid expansion of cell-based research and therapeutics, outsourcing cell banking has become a strategic necessity for many life sciences companies.

What Are the Key Growth Drivers Shaping the Future of the Cell Banking Outsourcing Market?

The growth in the cell banking outsourcing market is driven by several factors, including increasing demand for cell-based therapies, advancements in biopreservation technologies, and rising investments in biopharmaceutical research. One of the primary growth drivers is the expansion of clinical trials for cell and gene therapies, which require secure and well-maintained cell lines for development and regulatory approval. As pharmaceutical companies and research institutions accelerate their efforts in regenerative medicine, the need for reliable cell banking partners is becoming increasingly critical.

Another crucial driver shaping the market is the increasing adoption of personalized medicine and precision therapies. With cell-based treatments becoming more patient-specific, the demand for customized cell banking solutions, including autologous and allogeneic storage services, is on the rise. Additionally, partnerships between biopharmaceutical companies and contract development and manufacturing organizations (CDMOs) are expanding, allowing for more scalable and cost-effective outsourcing solutions. As the life sciences industry continues to innovate, cell banking outsourcing is expected to play a pivotal role in advancing therapeutic breakthroughs, ensuring long-term sample viability, and supporting the next generation of biopharmaceutical development.

SCOPE OF STUDY:

The report analyzes the Cell Banking Outsourcing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Master Cell Banking, Working Cell Banking, Viral Cell Banking); Cell Type (Stem Cells, Non-stem Cells); Phase (Bank Storage Phase, Bank Characterization and Testing Phase, Bank Preparation Phase)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • ATCC (American Type Culture Collection)
  • BioOutsource Ltd.
  • BioReliance Corporation
  • BSL Bioservice
  • CellBank Australia
  • Charles River Laboratories, Inc.
  • Clean Biologics
  • Cordlife Group Limited
  • Covance Inc.
  • Cryo-Cell International Inc.
  • Cryoviva India
  • Eurofins Scientific
  • GBI
  • LifeCell International Pvt. Ltd
  • Lonza Group Ltd.
  • Merck KGaA
  • Paragon Bioservices, Inc.
  • Reliance Life Sciences
  • Sartorius AG
  • SGS Life Sciences

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Cell Banking Outsourcing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Biologics and Cell-Based Therapies Throws the Spotlight on Cell Banking Outsourcing Solutions
    • Rapid Growth in Cell and Gene Therapy Pipelines Propels the Need for High-Quality Master and Working Cell Banks
    • Increasing Complexity of GMP and Regulatory Compliance Strengthens the Business Case for Outsourced Cell Banking Providers
    • Expansion of Personalized Medicine and Autologous Therapies Drives Custom Cell Bank Storage Requirements
    • Biopharmaceutical Shift Toward Outsourcing Models Fuels Growth in Contract Cell Banking Services
    • Growing Adoption of cGMP-Compliant Facilities Enhances Demand for Specialized Cell Storage and Characterization Services
    • Globalization of Clinical Trials and Manufacturing Operations Expands the Addressable Market for Multi-Site Cell Banking
    • Rising Investment in Stem Cell Research and Regenerative Medicine Creates New Service Demand in Cell Banking Logistics
    • Increased Focus on Supply Chain Risk Mitigation Spurs Interest in Redundant and Disaster-Proof Cell Storage Models
    • Expansion of Allogeneic Cell Therapy Platforms Accelerates Demand for Scalable Banking Infrastructure
    • Stringent Quality Control, Authentication, and Contamination Prevention Standards Drive Laboratory Automation Adoption
    • Emergence of Biobanking-as-a-Service (BaaS) Models Creates Flexible Access for Smaller Biotech Firms
    • Integration of Digital Chain-of-Custody and Sample Tracking Technologies Enhances Service Transparency and Reliability
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cell Banking Outsourcing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cell Banking Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Cell Banking Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Master Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Master Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Master Cell Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Working Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Working Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Working Cell Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Viral Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Viral Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Viral Cell Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Non-stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Non-stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Non-stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Bank Storage Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Bank Storage Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Bank Storage Phase by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Bank Characterization & Testing Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Bank Characterization & Testing Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Bank Characterization & Testing Phase by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Bank Preparation Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Bank Preparation Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Bank Preparation Phase by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • JAPAN
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • CHINA
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • EUROPE
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Cell Banking Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Cell Banking Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • FRANCE
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • GERMANY
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Cell Banking Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • INDIA
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: India 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Cell Banking Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Cell Banking Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Cell Banking Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Cell Banking Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • AFRICA
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제